Nepal: COVID-19 Emergency Response and Health Systems Preparedness Project

Abstract*

The project development objective is to prevent, detect and respond to the threat posed by COVID-19 and to strengthen national systems for public health preparedness in Nepal. It will achieve this objective by supporting the Government of Nepal, and specifically the Ministry of Health and Population (MoHP), to (i) provide emergency COVID-19 response for better case detection, confirmation, contact tracing, recording, and reporting as well for strengthening...

* The project abstract is drawn from the PAD, SAR or PGD and may not accurately reflect the project's current nature

Show More

Development Objective

The project development objective is to prevent, detect and respond to the threat posed by COVID-19 and to strengthen national systems for public health preparedness in Nepal.

Key Details

Project Details

  • P173760

  • Closed

  • Anna Koziel

  • Government of Nepal,Government of Nepal

  • Nepal

  • March 29, 2020

  • (as of board presentation)

    April 3, 2020

  • April 7, 2020

  • US$ 29.00 million

  • Ministry of Health and Population,Ministry of Health and Population

  • South Asia

  • 2020

  • US$ 104.00 million

  • N/A

  • Substantial

  • July 15, 2024

  • Bank Approved

  • May 1, 2024

  • Notes

Finances

Financing Plan (US$ Millions)

No data available.
Financier Commitments
IDA Credit 104.00
IDA Credit 104.00

Total Project Financing (US$ Millions)

Product Line IBRD/IDA
IBRD Commitment N/A
IDA Commitment 104.00
IBRD + IDA Commitment 104.00
Lending Instrument
Grant Amount N/A
Total Project Cost** 29.00

Summary Status of World Bank Financing (US$ Millions) as of October 31, 2025

Download:
No data available.
Financier Approval Date Closing Date Principal Disbursed Repayments Interest, Charges & Fees

Detailed Financial Activity as of October 31, 2025

Download:
No data available.
Period Financier Transaction Type Amount (US$)

Footnotes

Ratings

IMPLEMENTATION RATINGS

Name Review Date
Financial Management Moderately Unsatisfactory 2025-01-27
Financial Management Moderately Unsatisfactory 2025-01-27
Monitoring and Evaluation Satisfactory 2025-01-27
Monitoring and Evaluation Satisfactory 2025-01-27
Overall Implementation Progress (IP) Moderately Satisfactory 2025-01-27
Overall Implementation Progress (IP) Moderately Satisfactory 2025-01-27
Procurement Moderately Satisfactory 2025-01-27
Procurement Moderately Satisfactory 2025-01-27
Progress towards achievement of PDO Satisfactory 2025-01-27
Progress towards achievement of PDO Satisfactory 2025-01-27
Project Management Moderately Satisfactory 2025-01-27
Project Management Moderately Satisfactory 2025-01-27

COMPLETION RATINGS

No data available.

INDEPENDENT EVALUATION RATINGS

No data available.

Results Framework

PROJECT DEVELOPMENT OBJECTIVE INDICATORS

INDICATORBASELINECURRENTTARGET
  • Proportion of cold chain capacity gaps filled.Value0.00746.3660.00
    DateJanuary 1, 2021February 15, 2024July 15, 2024
    Comment
  • Proportion of cold chain capacity gaps filled.Value0.00746.3660.00
    DateJanuary 1, 2021February 15, 2024July 15, 2024
    Comment
  • Proportion of female community health volunteers fully vaccinated, as per protocolValue0.0093.0060.00
    DateJanuary 1, 2021February 15, 2024July 15, 2024
    Comment
  • Proportion of female community health volunteers fully vaccinated, as per protocolValue0.0093.0060.00
    DateJanuary 1, 2021February 15, 2024July 15, 2024
    Comment
  • Proportion of prioritized female population fully vaccinated, as per protocolValue0.0053.4050.00
    DateJanuary 1, 2021February 15, 2024July 15, 2024
    Comment
  • Proportion of prioritized female population fully vaccinated, as per protocolValue0.0053.4050.00
    DateJanuary 1, 2021February 15, 2024July 15, 2024
    Comment
  • Proportion of prioritized male population fully vaccinated, as per protocolValue0.0046.6050.00
    DateJanuary 1, 2021February 15, 2024July 15, 2024
    Comment
  • Proportion of prioritized male population fully vaccinated, as per protocolValue0.0046.6050.00
    DateJanuary 1, 2021February 15, 2024July 15, 2024
    Comment
  • Proportion of prioritized population fully vaccinated, as per protocol, disaggregated by genderValue0.0096.3050.00
    DateJanuary 1, 2021February 15, 2024July 15, 2024
    Comment
  • Proportion of prioritized population fully vaccinated, as per protocol, disaggregated by genderValue0.0096.3050.00
    DateJanuary 1, 2021February 15, 2024July 15, 2024
    Comment
  • Proportion of vaccination sites/outreach with at least one female health care provider/volunteerValue0.0093.6480.00
    DateJanuary 1, 2021February 15, 2024July 15, 2024
    Comment
  • Proportion of vaccination sites/outreach with at least one female health care provider/volunteerValue0.0093.6480.00
    DateJanuary 1, 2021February 15, 2024July 15, 2024
    Comment

INTERMEDIATE RESULTS INDICATORS

INDICATORBASELINECURRENTTARGET
  • A National Deployment and Vaccination Plan (NDVP) is approved and adoptedValueNoYesYes
    DateJanuary 1, 2021February 15, 2024July 15, 2024
    Comment
  • A National Deployment and Vaccination Plan (NDVP) is approved and adoptedValueNoYesYes
    DateJanuary 1, 2021February 15, 2024July 15, 2024
    Comment
  • Joint supervision and monitoring visits conductedValue0.0010.004.00
    DateJanuary 10, 2020February 15, 2024July 15, 2024
    Comment
  • Joint supervision and monitoring visits conductedValue0.0010.004.00
    DateJanuary 10, 2020February 15, 2024July 15, 2024
    Comment
  • M&E system established to monitor COVID-19 preparedness and response planValueNoYesYes
    DateJanuary 10, 2020February 15, 2024July 15, 2024
    Comment
  • M&E system established to monitor COVID-19 preparedness and response planValueNoYesYes
    DateJanuary 10, 2020February 15, 2024July 15, 2024
    Comment
  • Nepal adopted personal and community non-pharmaceutical interventions (schools closures, telework and remote meetings, reduce/cancel mass gatheringsValueNoYesYes
    DateJanuary 10, 2020February 15, 2024July 15, 2024
    Comment
  • Nepal adopted personal and community non-pharmaceutical interventions (schools closures, telework and remote meetings, reduce/cancel mass gatheringsValueNoYesYes
    DateJanuary 10, 2020February 15, 2024July 15, 2024
    Comment
  • Nepal has activated its public Health Emergency Operations Centre or a coordination mechanism for COVID-19ValueNoYesYes
    DateJanuary 10, 2020February 15, 2024July 15, 2024
    Comment
  • Nepal has activated its public Health Emergency Operations Centre or a coordination mechanism for COVID-19ValueNoYesYes
    DateJanuary 10, 2020February 15, 2024July 15, 2024
    Comment
  • Nepal has contextualized its risk communication and community engagement strategiesValueNoYesYes
    DateJanuary 10, 2020February 15, 2024July 15, 2024
    Comment
  • Nepal has contextualized its risk communication and community engagement strategiesValueNoYesYes
    DateJanuary 10, 2020February 15, 2024July 15, 2024
    Comment
  • New/rehabilitated ICU beds established in the public hospitals for managing public health emergenciesValue0.002773.00135.00
    DateJanuary 10, 2020February 15, 2024July 15, 2024
    Comment
  • New/rehabilitated ICU beds established in the public hospitals for managing public health emergenciesValue0.002773.00135.00
    DateJanuary 10, 2020February 15, 2024July 15, 2024
    Comment
  • Number of acute healthcare facilities with isolation capacityValue1.0078.0050.00
    DateJanuary 10, 2020February 15, 2024July 15, 2024
    Comment
  • Number of acute healthcare facilities with isolation capacityValue1.0078.0050.00
    DateJanuary 10, 2020February 15, 2024July 15, 2024
    Comment
  • Number of acute healthcare facilities with triage capacityValue1.0030.0010.00
    DateJanuary 10, 2020February 15, 2024July 15, 2024
    Comment
  • Number of acute healthcare facilities with triage capacityValue1.0030.0010.00
    DateJanuary 10, 2020February 15, 2024July 15, 2024
    Comment
  • Number of designated laboratories with COVID-19 diagnostic equipment, test kits, and reagentsValue1.00110.0045.00
    DateJanuary 10, 2020February 15, 2024July 15, 2024
    Comment
  • Number of designated laboratories with COVID-19 diagnostic equipment, test kits, and reagentsValue1.00110.0045.00
    DateJanuary 10, 2020February 15, 2024July 15, 2024
    Comment
  • Number of designated laboratories with staff trained to conduct COVID-19 diagnosisValue1.00110.0045.00
    DateJanuary 10, 2020February 15, 2024July 15, 2024
    Comment
  • Number of designated laboratories with staff trained to conduct COVID-19 diagnosisValue1.00110.0045.00
    DateJanuary 10, 2020February 15, 2024July 15, 2024
    Comment
  • Number of health staff trained in infection prevention and control per MoHP approved protocolsValue0.0011899.001000.00
    DateJanuary 10, 2020February 15, 2024July 15, 2024
    Comment
  • Number of health staff trained in infection prevention and control per MoHP approved protocolsValue0.0011899.001000.00
    DateJanuary 10, 2020February 15, 2024July 15, 2024
    Comment
  • Percentage of specimens submitted for SARS-COV2 laboratory testing and confirmed within WHO stipulated standard timeValue0.00100.0090.00
    DateJanuary 10, 2020February 15, 2024July 15, 2024
    Comment
  • Percentage of specimens submitted for SARS-COV2 laboratory testing and confirmed within WHO stipulated standard timeValue0.00100.0090.00
    DateJanuary 10, 2020February 15, 2024July 15, 2024
    Comment
  • Proportion of SEA/SH calls received by COVID-19 helplines referred to OCMC or Women’s Commission for appropriate supportValue0.00100.0080.00
    DateJanuary 1, 2021February 15, 2024July 15, 2024
    Comment
  • Proportion of SEA/SH calls received by COVID-19 helplines referred to OCMC or Women’s Commission for appropriate supportValue0.00100.0080.00
    DateJanuary 1, 2021February 15, 2024July 15, 2024
    Comment
  • Proportion of callers to COVID-19 helplines satisfied with support/services providedValue0.0079.2560.00
    DateJanuary 1, 2021February 15, 2024July 15, 2024
    Comment
  • Proportion of callers to COVID-19 helplines satisfied with support/services providedValue0.0079.2560.00
    DateJanuary 1, 2021February 15, 2024July 15, 2024
    Comment
  • Symposium on surveillance, treatment and prophylaxis conductedValue0.006.004.00
    DateJanuary 10, 2020February 15, 2024July 15, 2024
    Comment
  • Symposium on surveillance, treatment and prophylaxis conductedValue0.006.004.00
    DateJanuary 10, 2020February 15, 2024July 15, 2024
    Comment